rs75852090
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001305581.2(LRMDA):c.611G>A(p.Gly204Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00509 in 1,613,916 control chromosomes in the GnomAD database, including 366 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.028 ( 195 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 171 hom. )
Consequence
LRMDA
NM_001305581.2 missense
NM_001305581.2 missense
Scores
3
7
6
Clinical Significance
Conservation
PhyloP100: 5.57
Genes affected
LRMDA (HGNC:23405): (leucine rich melanocyte differentiation associated) This gene encodes a leucine-rich repeat protein. The encoded protein is thought to play a role in melanocyte differentiation. Mutations in this gene have been associated with autosomal recessive oculocutaneous albinism 7 (OCA7). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0043112934).
BP6
Variant 10-76557218-G-A is Benign according to our data. Variant chr10-76557218-G-A is described in ClinVar as [Benign]. Clinvar id is 261992.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0933 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRMDA | NM_001305581.2 | c.611G>A | p.Gly204Glu | missense_variant | 7/7 | ENST00000611255.5 | NP_001292510.1 | |
LRMDA | NM_032024.5 | c.527G>A | p.Gly176Glu | missense_variant | 6/6 | NP_114413.1 | ||
LRMDA | NR_131178.2 | n.965G>A | non_coding_transcript_exon_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRMDA | ENST00000611255.5 | c.611G>A | p.Gly204Glu | missense_variant | 7/7 | 5 | NM_001305581.2 | ENSP00000480240 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0281 AC: 4266AN: 152064Hom.: 195 Cov.: 32
GnomAD3 genomes
AF:
AC:
4266
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00717 AC: 1804AN: 251456Hom.: 80 AF XY: 0.00510 AC XY: 693AN XY: 135898
GnomAD3 exomes
AF:
AC:
1804
AN:
251456
Hom.:
AF XY:
AC XY:
693
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00270 AC: 3942AN: 1461734Hom.: 171 Cov.: 30 AF XY: 0.00223 AC XY: 1619AN XY: 727190
GnomAD4 exome
AF:
AC:
3942
AN:
1461734
Hom.:
Cov.:
30
AF XY:
AC XY:
1619
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0281 AC: 4270AN: 152182Hom.: 195 Cov.: 32 AF XY: 0.0267 AC XY: 1987AN XY: 74406
GnomAD4 genome
AF:
AC:
4270
AN:
152182
Hom.:
Cov.:
32
AF XY:
AC XY:
1987
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
401
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
1100
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PROVEAN
Pathogenic
.;D;.
REVEL
Uncertain
Sift
Uncertain
.;D;.
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;.
Vest4
MVP
MPC
0.64
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at